DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 1, 2014, Pages 75-84

  Bodoor, Khaldon ^a   Haddad, Yazan ^a   Alkhateeb, Asem ^a   Al Abbadi, Abdullah ^b   Dowairi, Mohammad ^b   Magableh, Ahmad ^b   Bsoul, Nazzal ^b   Ghabkari, Abdulhameed ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Acute leukemia; Chronic leukemia; DAPK; DNA methylation; p14; p15; p16; p53; TMS1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYTOSKELETON PROTEIN; DEATH ASSOCIATED PROTEIN KINASE; PROTEIN P53; PYCARD PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; BLOOD; CELL CYCLE; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DNA METHYLATION; FEMALE; GENETICS; HUMAN; LEUKEMIA; MALE; MIDDLE AGED; PRESCHOOL CHILD; TUMOR SUPPRESSOR GENE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; APOPTOSIS; CELL CYCLE; CHILD; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYTOSKELETAL PROTEINS; DEATH-ASSOCIATED PROTEIN KINASES; DNA METHYLATION; FEMALE; GENES, P16; GENES, P53; HUMANS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84894073785     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.1.75     Document Type: Article

References (95)

1. Aggerholm A, Holm MS, Guldberg P, Olesen LH, Hokland P (2006). Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients. Eur J Haematol, 76, 23-32.
2. Aggire X, Vismanos J, Calasanz M, et al (2003). Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decresed gene expression in a subset of acute lymphoblastic leukemia patients. Oncogene. 22, 1070-2.
3. Agrawal S, Unterberg M, Koschmieder S, et al (2007). DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia. Cancer Res, 67, 1370-7.
4. Brakensiek K, Langer F, Kreipe H, Lehmann U (2005). Absence of p21(CIP 1), p27(KIP 1) and p 57(KIP 2) methylation in MDS and AML. Leuk Res. 29, 1357-60.
5. Canalli A, Yang H, Jeha S, et al (2005). Aberrant DNA methylation of a cell cycle regulatory pathway composed of P73, P15 and P57KIP2 is a rare event in children with acute lymphocytic leukemia. Leuk Res, 29, 881-5.
6. Cechova H, Lassuthova P, Novakova L, et al (2012) Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia. Neoplasma, 59, 168-74.
7. Chen H, Wu S (2002). Hypermethylation of the p15(INK4B) gene in acute leukemia and myelodysplastic syndromes. Chin Med J (Engl), 115, 987-90.
8. Chim C, Tam C, Liang R, Kwong Y (2001). Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance. Cancer, 91, 2222-9.
9. Chim C, Wong A, Kwong Y (2003). Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias. Ann Hematol, 82, 738-42.
10. Chim C, Fung T, Wong K, et al (2006a). Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients. J Clin Pathol, 59, 921-6.
11. Chim C, Fung T, Wong K, Lau J, Liang R (2006b). Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia. J Hum Genet, 51, 832-8.
12. Chim C, Chan W, Kwong Y (2008). Epigenetic dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in acute leukaemias. J Clin Pathol, 61, 844-7.
13. Christiansen D, Andersen M, Pedersen-Bjergaard J (2003). Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia. Leukemia, 17, 1813-9.
14. Cohen O, Kimchi A (2001). DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer. Cell Death Differ, 8, 6-15.
15. Costello J, Fruhwald M, Smiraglia D, et al (2000). Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet, 24, 132-8.
16. Das P, Ramachandran K, Vanwert J, et al (2006). Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Molecular Cancer, 5, 28.
17. Deligezer U, Erten N, Akisik E, Dalay N (2006). Methylation of the INK4A/ARF locus in blood mononuclear cells. Ann Hematol, 85, 102-7.
18. Di Croce L (2005). Chromatin modifying activity of leukaemia associated fusion proteins. Hum Mol Genet, 14, 77-84.
19. Ding S, Gong B, Yu J, et al (2004). Methylation profile of the promoter CpG islands of 14 "drug-resistance" genes in hepatocellular carcinoma. World J Gastroenterol, 10, 3433-40.
20. Dodge J, Munson C (2001). List AF. KG-1 and KG-1a model the p15 CpG island methylation observed in acute myeloid leukemia patients. Leuk Res, 25, 917-25.
21. Ekmekci C, Gutierrez M, Siraj A, Ozbek U, Bhatia K (2004). Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia. Am J Hematol, 77, 233-40.
22. El-Shakankiry N, Mossallam G (2006). p15 (INK4B) and E-cadherin CpG island methylation is frequent in Egyptian acute myeloid leukemia. J Egypt Natl Canc Inst, 18, 227-32.
23. Esteller M, Tortola S, Toyota M, et al (2000). Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res, 60, 129-33.
24. Esteller M, Gonzalez S, Risques R, et al (2001). K-ras and p16 aberrations confer poor prognosis in human colorectal cancer. J Clin Oncol, 19, 299-304.
25. Esteller M (2002). CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene, 21, 5427-40.
26. Galm O, Wilop S, Luders C, et al (2005). Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia. Ann Hematol, 84, 39-46.
27. Galm O, Herman J, Baylin S (2006). The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev, 20, 1-13.
28. Garcia-Manero G, Bueso-Ramos C, Daniel J, et al (2002a). DNA methylation patterns at relapse in adult acute lymphocytic leukemia. Clin Cancer Res, 8, 1897-903.
29. Garcia-Manero G, Daniel J, Smith T, et al (2002b). DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia. Clin Cancer Res, 8, 2217-24.
30. Garcia-Manero G, Jeha S, Daniel J, et al (2003). Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia. Cancer, 97, 695-702.
31. Griffiths E, Gore S, Hooker C, et al (2010) Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia. Epigenetics, 5, 590-600.
32. Guinn B, Mills K (1997). p53 mutations, methylation and genomic instability in the progression of chronic myeloid leukemia. Leukemia Lymphoma, 26, 211-26.
33. Guo S, Taki T, Ohnishi H, et al (2000). Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia. Leuk Res, 24, 39-46.
34. Guran S, Bahce M, Beyan C, Korkmaz K, Yalcin A (1998). P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia. Haematologia (Budap). 29, 181-93.
35. Herman J, Graff, J, Myohanen S, Nelkin B, Baylin S (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 93, 9821-6.
36. Herman J, Civin C, Issa J, et al (1997). Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res, 57, 837-41.
37. Hofmann W, Takeuchi S, Takeuchi N, et al (2006). Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome. Leuk Res, 30, 1347-53.
38. Iravani M, Dhat R, Price C (1997). Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia. Oncogene, 15, 2609-14.
39. Jemal A, Siegel R, Ward E, et al (2008). Cancer statistics 2008. CA Cancer J Clin, 58, 71-96.
40. Johnson D, Walker C (1999). Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol, 39, 295-312.
41. Jones P, Baylin S (2007). The epigenomics of cancer. Cell. 128, 683-92.
42. Kapelko-Slowik K, Wolowiec D, Sedek K, et al (2002). [Expression of p16INK4a, p15INK4b, p21WAF1/Clip1 cell cycle inhibitors on blastic cells in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) ]. Pol Arch Med Wewn, 108, 849-53.
43. Katzenellenbogen R, Baylin S, Herman J (1999). Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood, 93, 4347-53.
44. Kim M, Yim S, Cho N,et al (2009) Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study. Cancer Genetics and Cytogenetics, 195, 59-65.
45. Krug U, Ganser A, Koeffler H (2002). Tumor suppressor genes in normal and malignant hematopoiesis. Oncogene, 21, 3475-95.
46. Kuiper R, Schoenmakers E, Van Reijmersdal S, et al (2007). High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia, 21, 1258-66.
47. Kurtovic N, Krajnovic M, Bogdanovic A, et al (2012) Concomitant aberrant methylation of p15 and MGMT genes in acute myeloid leukemia: association with a particular immunophenotype of blast cells. Med Oncol, 29, 3547-56.
48. Kusy S, Cividin M, Sorel N, et al (2003). p14ARF, p15INK4b, and p16INK4a methylation status in chronic myelogenous leukemia. Blood, 101, 374-5.
49. Lehmann U, Brakensiek K, Kreipe H (2004). Role of epigenetic changes in hematological malignancies. Ann Hematol, 83, 137-52.
50. Levine A (1997). p53, the cellular gatekeeper for growth and division. Cell, 88, 323-31.
51. Markus J, Garin M, Bies J, et al (2007). Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16). Cancer Res, 67, 992-1000.
52. Masumoto J, Dowds T, Schaner P, et al (2003). ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochem Biophys Res Commun, 303, 69-73.
53. Matsuno N, Hoshino K, Nanri T, et al (2005). p15 mRNA expression detected by real-time quantitative reverse transcriptase-polymerase chain reaction correlates with the methylation density of the gene in adult acute leukemia. Leuk Res, 29, 557-64.
54. Matsushita C, Yang Y, Takeuchi S, et al (2004). Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia. Oncol Rep, 12, 97-9.
55. Melki J, Vincent P, Clark S (1999). Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res, 59, 3730-40.
56. Milani L, Lundmark A, Kiialainen A et al (2010). DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. Blood, 115, 1214-25.
57. Morse L, Chen D, Franklin D, Xiong Y, Chen-Kiang S (1997). Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6. Immunity, 6, 47-56.
58. Nagasawa T, Zhang Q, Raghunath P, et al (2006). Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing. Leuk Res, 30, 303-12.
59. Nguyen T, Mohrbacher A, Tsai Y, et al (2000). Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications. Blood, 95, 2990-2.
60. Nguyen C, Liang G, Nguyen T (2001). Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J Natl Cancer Inst, 93, 1465-72.
61. Nosaka K, Maeda M, Tamiya S, et al (2000). Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia. Cancer Res, 60, 1043-8.
62. NovaraF, Beri S, Bernardo M, et al (2009) Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood. Hum Genet, 126, 511-20.
63. Olesen L, Nyvold C, Aggerholm A, et al (2005). Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL. Eur J Haematol, 75, 185-92.
64. Ozkul Y, Jurickova I, Findley H (2002). Variable Expression and Hypermethylation of p16 Gene in Patients with T-ALL and Cell Lines. Turk J Haematol, 19, 391-7.
65. Parsons M, Vertino P (2006). Dual role of TMS1/ASC in death receptor signaling. Oncogene, 25, 6948-58.
66. Raval A, Tanner S, Byrd J, et al (2007). Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell, 129, 879-90.
67. Raveh T, Berissi H, Eisenstein M, Spivak T, Kimchi A (2000). A functional genetic screen identifies regions at the C-terminal tail and death-domain of death-associated protein kinase that are critical for its proapoptotic activity. Proc Natl Acad Sci USA. 97, 1572-7.
68. Raveh T, Droguett G, Horwitz M, Depinho R, Kimchi A (2001). DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat Cell Biol, 3, 1-7.
69. Robson C, Gnanapragasam V, Byrne R, Collins A, Neal D (1999). Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium. J Endocrinol, 160, 257-66.
70. Roman-Gomez J, Jimenez-Velasco A, Castillejo J, et al (2004). Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood, 104, 2492-8.
71. Roman-Gomez J, Jimenez-Velasco A, Agirre X, et al (2005). Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J Clin Oncol, 23, 7043-9.
72. Roman-Gomez J, Jimenez-Velasco A, Agirre X, et al (2006). Promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis with opposing effects on clinical outcome. Leukemia, 20, 1445-8.
73. Scholz C, Nimmrich I, Burger M, et al (2005). Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis. Ann Hematol, 84, 236-44.
74. Schwaller J, Pabst T, Koeffler H, et al (1997). Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells. Leukemia, 11, 54-63.
75. Scott S, Kimura T, Dong W, et al (2004). Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia. Leuk Res, 28, 1293-301.
76. Scott S, Dong W, Ichinohasama R, et al (2006). 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation. Leuk Res, 30, 69-76.
77. Seeliger B, Wilop S, Osieka R, Galm O, Jost E (2009) CpG island methylation patterns in chronic lymphocytic leukemia. Leuk & Lymph, 50, 419-26.
78. Shimamoto T, Ohyashiki J, Ohyashiki K (2005). Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia. Leuk Res, 29, 653-9.
79. Stehlik C, Lee S, Dorfleutner A, et al (2003). Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J Immunol, 171, 6154-63.
80. Takeuchi S, Matsushita M, Zimmermann M, et al (2011) Clinical Significance of Aberrant DNA Methylation in Childhood Acute Lymphoblastic Leukemia. Leuk Res, 35, 1345-9.
81. Tang X, Khuri F, Lee J, et al (2000). Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst, 92, 1511-6.
82. Toyota M, Kopecky K, Toyota M, et al (2001). Methylation profiling in acute myeloid leukemia. Blood, 97, 2823-9.
83. Tsirigotis P, Pappa V, Labropoulos S, et al (2006). Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia. Eur J Haematol, 76, 230-6.
84. Uehara E, Takeuchi S, Yang Y, et al (2012) Aberrant methylation in promoter-associated CpG islands of multiple genes in chonic myelogenous leukemia blast crisis. Oncol Lett, 3, 190-2.
85. Valganon M, Giraldo P, Aggire X, et al (2005). p53 abberations do not predict individual response to fludarabine in patients with B-cell chronic lymophcytic leukemia in advanced stages Rai III/IV. Brit J Haematol, 129, 53-9.
86. Vilas-Zornoza A, Agirre X, Martin-Palanco V, et al (2011) Frequent and Simultaneous Epigenetic Inactivation of TP53Pathway Genes in Acute Lymphoblastic Leukemia. PLoS ONE, 6, 17012.
87. Wang R, Gehrke C, Ehrlich M (1980). Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues. Nucleic Acids Res, 8, 4777-90.
88. Wei Q, Claus R, Hielscher T, et al (2013). Germline Allele-Specific Expression of DAPK1 in Chronic Lymphocytic Leukemia. PLoS ONE, 8, 55261.
89. Wolff L, Bies J (2013) p15Ink4b Functions in determining hematopoietic cell fates: Implications for its role as a tumor suppressor. Blood Cells, Molecules and Diseases, 50, 227-31.
90. Wong I, Ng M, Huang D, Lee J (2000). Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications. Blood, 95, 1942-9.
91. Wright K, Deshmukh M (2006). Restricting apoptosis for postmitotic cell survival and its relevance to cancer. Cell Cycle, 5, 1616-20.
92. Wu Q, Guo X, Fan H, et al (2000). [P15(INK4B) gene methylation in malignant hematopoietic diseases]. Zhonghua Xue Ye Xue Za Zhi, 21, 644-6.
93. Yang Y, Takeuchi S, Hofmann W, et al (2006). Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia. Leuk Res, 30, 98-102.
94. Yang H, Kadia T, Xiao L. et al (2009). Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia. Blood, 113, 1892-8.
95. Zemliakova V, Strel'nikov V, Zborovskaia I, et al (2004). Abnormal methylation of p16/CDKN2A AND p14/ARF genes GpG Islands in non-small cell lung cancer and in acute lymphoblastic leukemia. Mol Biol, 38, 966-72.